Transcutaneous Electrical Nerve Stimulation for Labor Pain Control

Labor Pain Clinical Trial

Official title:

Transcutaneous Electrical Nerve Stimulation as a Pain-relieving Approach in Labor Pain Control: a Randomized Double-blinded Controlled Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04894539
• Other study ID #: 20190821
• Status: Completed
• Phase: N/A
• Start date: August 1, 2019
• Est. completion date: June 6, 2021

Study information

• Verified date: July 2021
• Source: Aalborg University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Transcutaneous electrical nerve stimulation (TENS) is a non-invasive electro-physical modality used for several pain conditions including labor pain control. Despite several years of research, there is still no agreement within the literature regarding the selection of TENS parameters. It is aimed to investigate two types of TENS frequencies (TENS1 alternating between 4 to 100 Hz and TENS2 alternating between 80 to 100 Hz) compared to sham-TENS.

Description:

Midwives and the study investigator will ask parturients, who are admitted to the labor ward at Region Hospital Herning satisfying the inclusion and exclusion criteria, whether they are interested in attending the experimental session.

The study will be conducted as soon as the subject is admitted at the labor ward. The study will only be conducted during early and active labor and not during the birth of the baby.

The subject in this study includes the package of a parturient and her neonate (after birth) as we also obtain data about the neonate. Hereby, two consent forms will be obtained. As this study is a non-invasive study, it is decided to have at least the consent of one parent.

The investigator will fill out a questionnaire about the parturient in cooperation with the subject and midwife, including screening questions related to inclusion and exclusion criteria before the experimental session starts.

The study will last approximately one hour and will be conducted during laboring circumstances. KT (Kenoja Thuvarakan) will carry out the experiment, and she will be present in the delivery room during the whole session.

The study includes several outcomes, including subjective and semi-objective pain measures. The primary outcome is VAS (0-10 cm scale), while secondary outcomes include PPT and satisfaction questionnaire (only at the end of the study). The subjects will be asked before, and immediately after the experimental exposure about the four outcomes (VAS and PPT). The subjects will be exposed to one of the two combinations of TENS stimulation (low and high alternating frequency), which will be compared to sham-TENS.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: June 6, 2021
• Est. primary completion date: April 5, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 39 Years

Eligibility

Inclusion Criteria:

• Singleton pregnancy

• Between ages 18-39 years

• Vertex presentation

• Speak, read and understand Danish

• At term (37-42 weeks gestation age)

Exclusion Criteria:

• High-risk pregnancies (including risk factors: eclampsia, pre-eclampsia, diabetes, gestational diabetes, hypertension, and hypotension, intrauterine growth restriction, polyhydramnios, and oligohydramnios).

• Pre-gestational body mass index above 40 kg/m2

• Use of fetal-scalp electrode during the experiment

• Use of pacemakers and other electronic implants

• Severe arrhythmia

• Present musculoskeletal/neurological illnesses

• Chronic pain within last 6 months

• Present medicated mental disorders

• Dermatological disorders

• Use of other long-acting pain relief

• Use of TENS 48 hours before the trial

• Drug addiction defines as the use of cannabis, opioids, or other drugs.

• Smokers

• Lack of ability to cooperate

Related Conditions & MeSH terms

• Labor Pain

Intervention

Device:
• DS5 electrical stimulator
TENS

Locations

Country	Name	City	State
Denmark	Region Hospital Gødstrup	Herning

Sponsors (3)

Lead Sponsor	Collaborator
Aalborg University	Centaflow, Herning Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Visual Analog scale (VAS)	10-cm pain intensity scale with 0 cm is no pain and 10 cm is unbearable pain. Decreased cm after baseline measurement indicates pain relief.	Baseline, 10 minutes post stimulation, 30 minutes post stimulation
Primary	Change in Pain pressure threshold	Pain sensitivity measurement also defined as the minimum pressure needed to evoke a pain response measured in kPa. Increased kPa after baseline measurement indicates pain relief.	Baseline, 10 minutes post stimulation, 30 minutes post stimulation
Secondary	Satisfaction of TENS	Satisfaction rating on scale from 0 to 10 [0 as 'no satisfaction' and 10 as 'total satisfaction'].	Right after last measurements of VAS & PPT
Secondary	Experienced pain reduction	Response to yes or no	Right after last measurements of VAS & PPT
Secondary	Interest in the use of TENS again	Response to yes, no, or don't know	Right after last measurements of VAS & PPT
Secondary	Recommend TENS to others	Response to yes, no, or don't know	Right after last measurements of VAS & PPT